Pneumococcal

1. Prevnar 13® (PCV13) AND Pneumovax 23® (PPSV23) are both recommended.8
2. Single dose of PCV13 should be given to patients who have not previous received PCV13.
3. PPSV23 should be given 8 weeks after PCV13 for those who have not previously received PPSV23.
4. One-time revaccination of PPSV23 should be administered 5 years after the first dose.

Haemophilus Influenzae Type B (Hib)

Single dose of any Hib conjugate vaccine (PedvaxHIB®, ActHIB®, or Hiberix®) is recommended for those who have not previously been vaccinated for Hib.9

Meningococcal

1. Vaccination for serogroup B (MenB) as well as serogroups A, C, W, and Y (MenACWY) is recommended.10,11,12
2. For those not previously vaccinated for MenB, either Bexsero® (2 dose series) or Trumenba® (3 dose series) may be given.
3. For those not previously vaccinated for MenACWY, either Menveo® or Menactra® should be administered as a 2 dose primary series. After the primary series, a booster dose is recommended every 5 years.
4. For those that have been vaccinated for MenACWY within 5 years, no booster is needed. If vaccinated beyond 5 years, a booster dose should be administered.
5. If Menactra® is the only MenACWY vaccine available and the patient also is recommended to get Prevnar 13®, Menactra® should be administered 4 weeks after Prevnar 13®.